
-
Heathrow 'warned about power supply' days before shutdown
-
Epstein accuser Virginia Giuffre 'stable' after car crash
-
Myanmar quake survivors plead for more help
-
Greece to spend 25 bn euros in 'drastic' defence overhaul: PM
-
Maresca non-committal over Sancho's future at Chelsea
-
WHO facing $2.5-bn gap even after slashing budget: report
-
Real Madrid coach Ancelotti tells tax trial did not seek to defraud
-
Chinese tourists pine for Taiwan's return as Beijing jets surround island
-
Singapore detains teenage boy allegedly planning to kill Muslims
-
What is the 'Qatargate' scandal roiling Israel?
-
AI coming for anime but Ghibli's Miyazaki irreplaceable, son says
-
Swedish insurer drops $160 mn Tesla stake over labour rights
-
Hunger returns to Gaza as Israeli blockade forces bakeries shut
-
Rubio heads to Europe as transatlantic tensions soar
-
Like 'living in hell': Quake-hit Mandalay monastery clears away rubble
-
'Give me a break': Trump tariffs threaten Japan auto sector
-
US approves $5.58 bn fighter jet sale to Philippines
-
Tsunoda embracing pressure of Red Bull debut at home Japanese GP
-
'Outstanding' Hay shines as New Zealand seal Pakistan ODI series
-
El Salvador's Bukele flaunts 'iron fist' alliance with Trump
-
Stock markets mixed as uncertainty rules ahead of Trump tariffs
-
China probes for key target weak spots with 'paralysing' Taiwan drills
-
'Top Gun' and Batman star Val Kilmer dies aged 65: New York Times
-
US lawmakers seek to rename street for Hong Kong's jailed Jimmy Lai
-
Greece to spend big on 'historic' military shake up
-
Trump faces first electoral setback after Wisconsin Supreme Court vote
-
Hay shines as New Zealand beat Pakistan for ODI series win
-
Israel says expands Gaza offensive to seize 'large areas'
-
Curry drops 52 as Warriors win, Jokic bags career-high 61 in Denver loss
-
South Korea mobilising 'all resources' for violence-free Yoon verdict
-
Myanmar quake victim rescued after 5 days as aid calls grow
-
Real Madrid coach Ancelotti tax fraud trial set to begin
-
Warner showcases 'Superman' reboot, new DiCaprio film
-
'Incredible' Curry scores 52 as Warriors down Grizzlies, Bucks edge Suns
-
Asian markets edge up but uncertainty rules ahead of Trump tariffs
-
Nintendo's megahit Switch console: what to know
-
Nintendo to unveil upgrade to best-selling Switch console
-
China practises hitting key ports, energy sites in Taiwan drills
-
Oil, sand and speed: Saudi gearheads take on towering dunes
-
All eyes on Tsunoda at Japan GP after ruthless Red Bull move
-
'Image whisperers' bring vision to the blind at Red Cross museum
-
Hay shines as New Zealand make 292-8 in Pakistan ODI
-
Other governments 'weaponising' Trump language to attack NGOs: rights groups
-
UK imposes online entry permit on European visitors
-
How a Brazilian chief is staving off Amazon destruction
-
Meme politics: White House embraces aggressive alt-right online culture
-
China launches military drills in Taiwan Strait
-
US senator smashes record with 25-hour anti-Trump speech
-
Brazil binman finds newborn baby on garbage route
-
US senator smashes record with marathon anti-Trump speech

EU watchdog approves new vaccines against bluetongue
The EU's medicines watchdog on Friday gave the thumbs up to two new vaccines against the bluetongue virus which struck parts of Europe from late 2023, infecting thousands of sheep, goats and cattle.
Bluetongue, a non-contagious, insect-borne viral disease that affects ruminants such as cows and sheep, has been spreading across Europe for more than a year.
The disease, also known as catarrhal fever, is difficult to control once it takes hold but is not a risk to humans.
The European Medicines Agency has "recommended the approval of the vaccines Bluevac-3 and Syvazul BTV 3 to protect sheep against bluetongue disease. Bluevac-3 is also approved for use in cattle," it said.
"These vaccines are shown to protect against the newly emerged serotype-3 bluetongue virus (BTV3), responsible for recent outbreaks in Europe, and against which vaccines currently approved at EU wide-level show little protection," the Amsterdam-based agency said.
The BTV-3 strain of the virus was first detected in the Netherlands in September 2023, before spreading to Germany the following month.
Cases have been recorded across Europe, including in Belgium, France, Italy, Spain and the Czech Republic.
Bluetongue is transmitted by biting midges. Symptoms in infected animals include high fevers, mouth ulcers and swollen heads.
It can lead to weakness and the loss of offspring for pregnant animals and is particularly deadly for sheep.
Climate change has worsened the spread of the virus, according to the United Nations' Food and Agriculture Organization (FAO), as global warming impacts midge populations.
Both the new vaccines contained an inactivated form of BTV3, which could not cause the disease, but triggered an immune response protecting the vaccinated animal, the EMA said.
Both were available as ready-to-use suspensions for injection, the agency added, saying it did not pose a risk to human or animal health.
The EMA's recommendation will now be sent to the European Commission to adopt a decision for EU-wide marketing authorisation.
L.Dubois--BTB